<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Susana Rubio-Guevara</style></author><author><style face="normal" font="default" size="100%">Olga Castillo-Medina</style></author><author><style face="normal" font="default" size="100%">Marleni Villacorta-Zavaleta</style></author><author><style face="normal" font="default" size="100%">Marleni Villacorta-Zavaleta</style></author><author><style face="normal" font="default" size="100%">Dan Altamirano-Sarmiento</style></author><author><style face="normal" font="default" size="100%">Elena Caceres-Andonaire</style></author><author><style face="normal" font="default" size="100%">Matilde Farias</style></author><author><style face="normal" font="default" size="100%">Nayly Chinchay</style></author><author><style face="normal" font="default" size="100%">Claudia Guerrero</style></author><author><style face="normal" font="default" size="100%">Josue Flores</style></author><author><style face="normal" font="default" size="100%">Edgar Vilela</style></author><author><style face="normal" font="default" size="100%">Sidny Nunez</style></author><author><style face="normal" font="default" size="100%">Janina Sernaque</style></author><author><style face="normal" font="default" size="100%">Felipe Pacherres</style></author><author><style face="normal" font="default" size="100%">Gabriela Mena</style></author><author><style face="normal" font="default" size="100%">Maria Trillo</style></author><author><style face="normal" font="default" size="100%">Julio Amayo</style></author><author><style face="normal" font="default" size="100%">Karyn Olascuaga-Castillo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vaccinium corymbosum: Phenolic Compound Content and Effect of Fruit Extract on Blood Glucose in Healthy Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animal studies</style></keyword><keyword><style  face="normal" font="default" size="100%">Blueberry</style></keyword><keyword><style  face="normal" font="default" size="100%">Hypoglycemic Effect</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin</style></keyword><keyword><style  face="normal" font="default" size="100%">Phenols</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 Diabetes.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">716-725</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; In the context of the increasing prevalence of metabolic diseases such as diabetes, the search for natural compounds with potential impact on glycemic regulation has become a crucial area of research. Among the numerous options available, &lt;em&gt;Vaccinium corymbosum&lt;/em&gt; extract, commonly known as &quot;blueberry&quot;, has emerged as a promising candidate due to its rich composition of phytochemicals with antioxidant, anti-inflammatory and hypoglycemic properties. The aim of this study was to determine the total phenolic content (TPC) and the activity of &lt;em&gt;Vaccinium corymbosum&lt;/em&gt; (&quot;blueberry&quot;) fruit extract on glycemia in healthy mice. &lt;strong&gt;Methods: &lt;/strong&gt;The Folin-Ciocalteau method was applied in order to quantify the phenolic compounds and the BE was administered to 25 mice distributed in six groups: control, negative control, experimental-D1- D2-D3, which were administered the BE in doses of 40, 80 and 120 mg/kg b.w. respectively; and insulin group; which were subjected to the glucose tolerance test (GTT) taking blood samples after 30, 60, 120 and 180 minutes. &lt;strong&gt;Results:&lt;/strong&gt; The total phenolic content (TPC) amount found in the berries was 3.79±0.06 GAE/dry weight (mg/g) and 18.96±0.28 GAE/solution (mg/L). Statistically significant differences were observed between the three doses of BE and the negative control during GTT as well as induced a significant reduction in area under the curve (AUC) compared to the negative control. &lt;strong&gt;Conclusions:&lt;/strong&gt; the three doses of the BE decreased glucose levels being the dose of 40 mg/kg b.w. the one that produced a statistically significant decrease with respect to the doses of 80 and 120 mg/kg b.w. during GTT.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">716</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Susana Rubio-Guevara&lt;sup&gt;1,2&lt;/sup&gt;, Olga Castillo-Medina&lt;sup&gt;1&lt;/sup&gt;, Marleni Villacorta- Zavaleta&lt;sup&gt;1&lt;/sup&gt;, Cyntia Blanco-Olano&lt;sup&gt;1&lt;/sup&gt;, Dan Altamirano-Sarmiento&lt;sup&gt;1&lt;/sup&gt;, Elena Cáceres-Andonaire&lt;sup&gt;1&lt;/sup&gt;, Matilde Farias&lt;sup&gt;2&lt;/sup&gt;, Nayly Chinchay&lt;sup&gt;2&lt;/sup&gt;, Claudia Guerrero&lt;sup&gt;2&lt;/sup&gt;, Josue Flores&lt;sup&gt;2&lt;/sup&gt;, Edgar Vilela&lt;sup&gt;2&lt;/sup&gt;, Sidny Nunez&lt;sup&gt;2&lt;/sup&gt;, Janina Sernaque&lt;sup&gt;2&lt;/sup&gt;, Felipe Pacherres&lt;sup&gt;2&lt;/sup&gt;, Gabriela Mena&lt;sup&gt;2&lt;/sup&gt;, Maria Trillo&lt;sup&gt;2&lt;/sup&gt;, Julio Amayo&lt;sup&gt;2&lt;/sup&gt;, Karyn Olascuaga-Castillo&lt;sup&gt;1 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;PharmaScience Research Group. Pharmacology Laboratory. School of Human Medicine.&amp;nbsp;Universidad Privada Antenor Orrego. Trujillo. PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;School of Human Medicine.&amp;nbsp;Universidad Privada Antenor Orrego. Piura. PERU.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dewi Sartika Ari Wanda</style></author><author><style face="normal" font="default" size="100%">Willy Sandhika</style></author><author><style face="normal" font="default" size="100%">Ridholia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">VDR and WNT/β-catenin Expression in Invasive Breast Carcinoma of No Special Type: Role and Prognostic Value</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Breast cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Invasive breast carcinoma of no special type</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D Receptor</style></keyword><keyword><style  face="normal" font="default" size="100%">β-catenin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1349-1354</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Breast cancer prognosis is closely related to tumor size (T stage). The Vitamin D receptor (VDR), found in about 80% of breast cancer cases, inhibits tumor growth, promotes differentiation, and enhances apoptosis. The growth of tumor cells is linked to β-Catenin, an essential element of the Wnt signaling pathway. Both β-catenin and VDR affect breast cancer aggressiveness. This study explored their correlation with the T stage of invasive breast carcinoma of no special type. &lt;strong&gt;Methods:&lt;/strong&gt; This research employed a cross-sectional design, applied on paraffin-embedded specimens from patients with invasive breast cancer of no special type (NST) who underwent modified radical mastectomy (MRM) at Dr. Soetomo General Academic Hospital from January 2019 to June 2023. The samples were categorized into four groups based on the T stage. Immunohistochemical staining was performed using VDR and β-catenin antibodies. This study used analytic statistical methods to examine differences and correlations among VDR and β-catenin.&lt;strong&gt; Results:&lt;/strong&gt; VDR expression and T stages were significantly different and negatively correlated. Expression of β-Catenin revealed significant differences and had positive correlations with T stages. VDR and β-catenin expressed no significant negative correlation with T stages. &lt;strong&gt;Conclusion:&lt;/strong&gt; The study found significant differences and correlations between VDR and β-catenin expression with T stages in invasive breast carcinoma of NST. Both β-catenin and VDR play crucial roles in breast cancer cell proliferation.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1349</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Dewi Sartika Ari Wanda&lt;sup&gt;1,2&lt;/sup&gt;, Willy Sandhika&lt;sup&gt;1,2*&lt;/sup&gt;, Ridholia&lt;sup&gt;1,2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Medical Staff at Anatomic Pathology Laboratory, Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Herin Setianingsih</style></author><author><style face="normal" font="default" size="100%">Nasywa Zahra Sajida Tsuroyya</style></author><author><style face="normal" font="default" size="100%">Prawesty Diah Utami</style></author><author><style face="normal" font="default" size="100%">Riami</style></author><author><style face="normal" font="default" size="100%">Nanang Wiyono</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Visual Mapping and Future Direction of Marine Products Supplementary and Chemotherapy in The Treatment of Breast Cancer. A Bibliometric</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anticancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Bibliometric</style></keyword><keyword><style  face="normal" font="default" size="100%">Breast cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Chemotherapy</style></keyword><keyword><style  face="normal" font="default" size="100%">Marine products</style></keyword><keyword><style  face="normal" font="default" size="100%">Visual mapping</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1379-1388</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Marine products have gained attention for their potential benefits in the treatment of breast cancer, offering an alternative or supplementary approach to traditional therapies. While they are not intended to replace established medical treatments like chemotherapy or surgery, marine natural products have shown promise in providing symptom relief, enhancing the quality of life, and potentially improving treatment success for breast cancer patients. Studies have explored the use of marine products in conjunction with chemotherapy for their palliative care benefits and as adjuvants to conventional therapies. Marinederived compounds have been investigated for their anticancer properties, including apoptosis induction, anti-proliferative effects, and modulation of signaling pathways involved in breast cancer progression. These natural products offer a complementary avenue for managing breast cancer, potentially enhancing treatment outcomes, and addressing therapeutic challenges. The utilization of marine products in breast cancer therapy dates back to ancient times when various cultures recognized the therapeutic benefits of plants, herbs, and marine resources. The purpose of this study is to visually map and guide future research on supplementary marine products and chemotherapy in breast cancer based on bibliometric analysis&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1379</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Herin Setianingsih&lt;sup&gt;1*&lt;/sup&gt;, Nasywa Zahra Sajida Tsuroyya&lt;sup&gt;1&lt;/sup&gt;, Prawesty Diah Utami&lt;sup&gt;1&lt;/sup&gt;, Riami&lt;sup&gt;1&lt;/sup&gt;, Nanang Wiyono&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Medicine, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Universitas Sebelas Maret, Surakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aditya Chrisdianto</style></author><author><style face="normal" font="default" size="100%">Prananda Surya Airlangga</style></author><author><style face="normal" font="default" size="100%">Belindo Wirabuana</style></author><author><style face="normal" font="default" size="100%">Regina Purnama Dewi Iskandar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vitamin D and Wound Recovery: Illuminating the Path to Enhanced Healing in Diabetic Patients</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Macrophage Polarisation</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D</style></keyword><keyword><style  face="normal" font="default" size="100%">Wound Healing</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">485-491</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Wound healing is a highly coordinated biological event as a response to injured skin. It commonly takes 14 days for a wound to be completely healed. However, the duration of wound healing may vary between individuals due to certain factors. One major factor that delays the wound-healing process is Diabetes Mellitus. Delayed wound healing with poor prognosis commonly occurs in diabetic patients. Chronic hyperglycemia may affect macrophage polarisation, which is essential in the wound healing mechanism. The macrophage polarisation enables the pro-inflammatory M1 phenotype to switch to the anti-inflammatory M2 phenotype. Thus, pro-inflammatory M1 phenotype prevails persistently in diabetic wounds, while the anti-inflammatory M2 phenotype remains deficient. It results in significantly elevated levels of pro-inflammatory cytokines triggered by the M1 phenotype. Prolonged wound healing times increase the risk of infection, which can lead to more severe complications. Vitamin D is widely recognized for its essential role in regulating calcium levels and supporting bone health, as well as its positive effects on the immune system. This vitamin has the potential to skew macrophages towards the M2 phenotype and promote a regenerative and anti-inflammatory environment.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">485</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Aditya Chrisdianto&lt;sup&gt;1&lt;/sup&gt;, Prananda Surya Airlangga&lt;sup&gt;2*&lt;/sup&gt;, Belindo Wirabuana&lt;sup&gt;2&lt;/sup&gt;, Regina Purnama Dewi Iskandar&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Master Program of Clinical Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Anaesthesiology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA. 3Department of Orthodontics, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Andiri Niza Syarifah</style></author><author><style face="normal" font="default" size="100%">Herman Suryadi</style></author><author><style face="normal" font="default" size="100%">Abdul Mun’im</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Validation of Rosmarinic Acid Quantification using High- Performance Liquid Chromatography in Various Plants</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">165-171</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: Rosmarinic acid has been utilized in traditional medicine as antioxidant, antiinflammation, anticancer and antibacterial. In order to control the herbal quality, validation of rosmarinic acid determination using high-performance liquid chromatography was developed. The objective of this report was to validate an HPLC technique for assessing rosmarinic acid levels. and application that method to determine rosmarinic acid in &lt;em&gt;Rosmarinus officinalis, Symphytum officinale, Mentha piperita, Orthosiphon stamineus &lt;/em&gt;and &lt;em&gt;Salvia officinale.&lt;/em&gt; &lt;strong&gt;Methods&lt;/strong&gt;: The chromatographic separation was carried out on a reversed-phase C18 column with a mobile phase of 0,1% formic acid and acetonitrile and an isocratic elution at a flow rate of 0,5 mL/min. The wavelength for detection was set to 330 nm. The method has been validated for precision, accuracy, linearity, limit of detection, and limit of quantitation. &lt;strong&gt;Result:&lt;/strong&gt; The concentration response of the detector was linear, with a coefficient of determination of 0.9933. The HPLC technique had an accuracy of 101,00 ± 6,43%. The precision was 6,36% when expressed as a coefficient of variation (CV). The highest level of rosmarinic acid was 214,86 ± 0,60 μg/mL in &lt;em&gt;Rosmarinus officinalis&lt;/em&gt; extract.&lt;strong&gt; Conclusion:&lt;/strong&gt; The HPLC method was valid to analyse rosmarinic acid level. The method can be applied in routine determination of rosmarinic acid of phytopharmaceutical products.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Key words:&lt;/strong&gt; Rosmarinic acid, HPLC, Laminaceae Borraginaceae.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">165</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Andiri Niza Syarifah&lt;sup&gt;1&lt;/sup&gt;, Herman Suryadi&lt;sup&gt;2,*&lt;/sup&gt;, Abdul Mun’im&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Bioavailability and Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacognosy- Phytochemistry, Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eny Purwoningsih</style></author><author><style face="normal" font="default" size="100%">Pepy Dwi Endraswari</style></author><author><style face="normal" font="default" size="100%">Agung Dwi Wahyu Widodo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vancomycin, Linezolid, and Ceftaroline In vitro Activity Against Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) Isolates</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">MRSA</style></keyword><keyword><style  face="normal" font="default" size="100%">MSSA</style></keyword><keyword><style  face="normal" font="default" size="100%">Time-kill curve</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">671-674</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;MRSA-infected patients incur twice as many costs as MSSA-infected patients. Vancomycin, Linezolid, and, most recently, Ceftaroline are among Indonesia's several MRSA treatment options. Therefore, we sought to assess the efficacy of these three medications. The investigation was done at the Dr. Soetomo General Academy Hospital's Clinical Microbiology Laboratory in Surabaya. The bacterium ATCC 25923, ATCC 43300, MSSA clinical isolate, and MRSA clinical isolate of &lt;em&gt;Staphylococcus aureus&lt;/em&gt; were studied. Vancomycin, Linezolid, and ceftaroline were administered at respective dosages of 1 MIC, 2 MIC, and 4 MIC. In addition, a time-kill test was performed, which consisted of counting the growth of colonies on solid media, generating a time-kill curve, and determining MBC. The number of colonies in the antibiotic groups at 4, 6, and 8 hours varied significantly, according to the study (Vancomycin, Linezolid, and Ceftaroline). In contrast, the number of bacteria did not differ significantly between Vancomycin and Linezolid until the fourth hour. Except at 6 and 24 hours, neither Vancomycin nor Ceftaroline significantly altered the number of bacteria. There was a significant difference in the number of colonies between Ceftaroline and Linezolid at 4, 6, and 8 hours. Vancomycin, Linezolid, and Ceftaroline against MSSA and MRSA isolates vary greatly.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">671</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Eny Purwoningsih&lt;sup&gt;1,*&lt;/sup&gt;, Pepy Dwi Endraswari&lt;sup&gt;2&lt;/sup&gt;, Agung Dwi Wahyu Widodo&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Clinical Microbiology, Faculty of Medicine, Airlangga University, Dr Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Clinical Microbiology, Airlangga University Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maulana Farid Rizki</style></author><author><style face="normal" font="default" size="100%">Paulus Sugianto</style></author><author><style face="normal" font="default" size="100%">Margarita Maria Maramis</style></author><author><style face="normal" font="default" size="100%">Soetjipto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Viral Meningoencephalitis Patient with Comorbid Major Depression with Psychotic Symptoms: A Case Report</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Comorbid</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Viral meningoencephalitis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">455-458</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Viral meningoencephalitis causes meninges and brain parenchyma inflammation, thus provoking significant morbidity and mortality. Clinical features include neurological and psychiatric symptoms depending on the brain involved, mild symptoms such as fever, headache, neck stiffness, and confusion, or severe symptoms such as seizures, weakness, hallucinations, and coma. Therefore, the clinical diagnosis and treatment of such cases are challenging to make. This case report describes an adult male patient suffering from viral meningoencephalitis with comorbid major depression with psychotic symptoms. The patient requires holistic management of meningoencephalitis with comorbid depression and neuropsychiatric symptoms that may occur in the long term.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Case Report</style></work-type><accession-num><style face="normal" font="default" size="100%">29</style></accession-num><section><style face="normal" font="default" size="100%">455</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Maulana Farid Rizki&lt;sup&gt;1&lt;/sup&gt;, Paulus Sugianto&lt;sup&gt;2,*&lt;/sup&gt;, Margarita Maria Maramis&lt;sup&gt;3&lt;/sup&gt;, Soetjipto&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Resident, Department of Neurology, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Medical Staff, Department of Neurology, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Medical Staff, Department of Psychiatry, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fathul Djannah</style></author><author><style face="normal" font="default" size="100%">Muhammad Nasrum Massi</style></author><author><style face="normal" font="default" size="100%">Mochammad Hatta</style></author><author><style face="normal" font="default" size="100%">Agussalim Bukhari</style></author><author><style face="normal" font="default" size="100%">Irda Handayani</style></author><author><style face="normal" font="default" size="100%">Muhammad Faruk</style></author><author><style face="normal" font="default" size="100%">Anny Setijo Rahaju</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virgin coconut oil and tuberculosis: A mini-review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Mycobacterium tuberculosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Tuberculosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Virgin coconut oil</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">464-469</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Virgin coconut oil is widely promoted and used as healthy and beneficial oil. One of them is caused by antimicrobials. Caprylic, caproic acid, capric acid, lauric acid and tau glyceryl monolaurate are other VCO compositions. Furthermore, due to the non-heating manufacturing process, the content in VCO can reduce cholesterol levels of triglycerides, LDL, phospholipids, VLDL and increase HDL in blood serum. VCO consumption lowers the number of&lt;em&gt; Mycobacterium tuberculosis &lt;/em&gt;colonies while increasing the conversion of BTA sputum. Until now, the prevalence of tuberculosis (TB) disease was extremely high. VCO can be used as a supplement to help TB patients recover faster.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Mini-Review</style></work-type><section><style face="normal" font="default" size="100%">464</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Fathul Djannah&lt;sup&gt;1,*&lt;/sup&gt;, Muhammad Nasrum Massi&lt;sup&gt;2&lt;/sup&gt;, Mochammad Hatta&lt;sup&gt;2&lt;/sup&gt;, Agussalim Bukhari&lt;sup&gt;3&lt;/sup&gt;, Irda Handayani&lt;sup&gt;4&lt;/sup&gt;, Muhammad Faruk&lt;sup&gt;5&lt;/sup&gt;, Anny Setijo Rahaju&lt;sup&gt;6,7&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomical Pathology, Faculty of Medicine, Universitas Mataram, Mataram, West Nusa Tenggara INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Clinical Nutrition, Faculty of Medicine, Universitas Hasanuddin, Makassar South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Clinical Pathology, Faculty of Medicine, Universitas Hasanuddin, Makassar South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Surgeon, Faculty of Medicine, Universitas Hasanuddin, Makassar South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Universitas Airlangga Academic Hospital, Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ali Nadeem</style></author><author><style face="normal" font="default" size="100%">Bashir Ahmed</style></author><author><style face="normal" font="default" size="100%">Hira Shahzad</style></author><author><style face="normal" font="default" size="100%">Lyle E. Craker</style></author><author><style face="normal" font="default" size="100%">Tudor Muntean</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Verbascum Thapsus (Mullein) Versatile Polarity Extracts: GC-MS Analysis, Phytochemical Profiling, Anti-bacterial Potential and Anti-oxidant Activity</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Microbiology</style></keyword><keyword><style  face="normal" font="default" size="100%">Verbascum Thapsus; GC/GC-MS; plant biotechnology</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1488-1497</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Verbascum thapsus is naturally grown in the Himalayas and widely used in herbal teas and traditional herbal medicine for its anticarcinogenic and anti-inflammatory properties. The present study was designed to majority of leaf extracts from Verbascum thapsus. All extracts were analysed for phytochemical properties, antioxidant capacity and antimicrobial potential against both Gram-positive and Gram-negative bacteria. Biochemical investigations and GC-MS analysis was used for identifying phytochemicals. DPPH assay, Kirby’s Disc Diffusion method (KDM), 96 well test, and Resazurin test were performed for antioxidant and antimicrobial investigation. Results indicate that verbascum thapsus grown in Pakistan is rich in alkaloids and phenols. Noteworthy antibacterial activity was observed against S. sonnei, L. lactis, B. subtilis, C. freundii, K. oxytoca, L. monocytogenes, and S. enterica. GCMS analyses of V. thapsus extracts revealed the presence of medically important bio compounds including Hexadecanoic acid, methyl es and Stigmasterol (antibacterial activity), 2(5H)-Furanone (appetite suppressant), 3-Hydroxy-.beta.-damascone (anti-inflammatory properties), Squalene (antiaging, anti-inflammatory, anti-acne, eczema), Vitamin E and 2-Methoxy-4-vinylphenol (antioxidants). Antioxidant radical scavenging activity was determined from acetone extract of V. thapsus. This study concludes remarkable antibacterial and antioxidant potential in Verbascum Thapsus leaf extracts&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1488</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ali Nadeem&lt;sup&gt;1&lt;/sup&gt;, Bashir Ahmed&lt;sup&gt;1&lt;/sup&gt;,*, Hira Shahzad&lt;sup&gt;2&lt;/sup&gt;, Lyle E. Craker&lt;sup&gt;3&lt;/sup&gt;, Tudor Muntean&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biological Sciences, International Islamic University, Islamabad, PAKISTAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biochemistry, PMAS Arid agriculture University, Rawalpindi, PAKISTAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Plant Biology, Stockbridge school of Agriculture, University of Massachusetts, Amherst, Massachusetts, USA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huynh Tan Hoi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vietnamese Medicinal Plants Useful in Treatments of Gout</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Gout</style></keyword><keyword><style  face="normal" font="default" size="100%">Health</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal herbs</style></keyword><keyword><style  face="normal" font="default" size="100%">Treatment</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1693-1697</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Gout is a metabolic pathology associated with an increase in the concentration of uric acid in the blood, characterized by episodes of acute arthritis or chronic arthritis caused by deposition of mononatri urate crystals in joints and connective tissue. Long ago, gout was considered a rare disease and a disease of the rich. Since the early years of the 21&lt;sup&gt;st&lt;/sup&gt; century, the incidence of gout and increased uric acid is increasing rapidly around the world. Clinical manifestations of the disease, the age and gender of the patient, related diseases, response to treatment, adverse consequences of the disease, its association with cardiovascular disease, kidney disease, etc. There are many changes in the negative direction that make the disease become incurable in many patients. Even in developed countries, the disease is not managed and monitored closely, increasing the rate of illness, death, disability and quality of life. The article focuses on the causes, manifestations of gout and, most importantly, the introduction of some herbs used in Vietnam. The scientific components, its effective effects have been confirmed by some documents and trusted by patients.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1693</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Huynh Tan Hoi*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Language Lecturer, FPT University, VIETNAM.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Novi Yantih</style></author><author><style face="normal" font="default" size="100%">Alfadella Methananda</style></author><author><style face="normal" font="default" size="100%">Yahdiana Harahap</style></author><author><style face="normal" font="default" size="100%">Wahono Sumaryono</style></author><author><style face="normal" font="default" size="100%">Lestari Rahayu</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Validation of High-Performance Liquid Chromatography for Determination of Bromelain in Pineapple (Ananas comosus (L) Merr) Water</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Bromelain</style></keyword><keyword><style  face="normal" font="default" size="100%">HPLC</style></keyword><keyword><style  face="normal" font="default" size="100%">Pineapple water</style></keyword><keyword><style  face="normal" font="default" size="100%">Storage</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">901-906</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The aim of the present study was to validate HPLC method for analysis bromelain levels in pineapple water and application that method to determine the storage time of pineapple water. &lt;strong&gt;Methods:&lt;/strong&gt; The reversed phase of HPLC method was tested and optimized before it is validated. The composition and the flow rate of the mobile phase is the optimized parameter. The analytical parameters validated were detection limits, linearity, accuracy and precision. Pineapple water was stored for 8 h at 10ºC and bromelain was determined using the validated HPLC method.&lt;strong&gt; Result: &lt;/strong&gt;The optimum mobile phase composition was methanolwater (70:30) with a flow rate of 1 ml/min. The detector concentration-response was linear with coefficient of determination of 0.993. The accuracy of HPLC method at a recovery of 1 and 2% bromelain was 106.37 ± 1.94% and 98.12 ± 1.29% (n = 5), respectively. The precision, expressed as the coefficients of variation (CV), at 1 and 2% bromelain were 1.83 and 1.32% (n = 5), respectively. Bromelain level at zero time was 81.53%. After storage for 8 h at 10ºC, bromelain levels in pineapple juice appeared to decrease not statistically significant (p &amp;gt; 0.05), with to mean value of 78.46 ± 2.88%. &lt;strong&gt;Conclusion:&lt;/strong&gt; The HPLC method developed was valid to analyze accurately concentrations of bromelain in pineapple water and it can be used to study the shelf life of pineapple water based on bromelain content. The bromelain content in pineapple juice was not statistically significantly different after 8 h storage at 10°C.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">901</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Novi Yantih&lt;sup&gt;1,&lt;/sup&gt;*, Alfadella Methananda&lt;sup&gt;1&lt;/sup&gt;, Yahdiana Harahap&lt;sup&gt;2&lt;/sup&gt;, Wahono Sumaryono&lt;sup&gt;1&lt;/sup&gt;, Lestari Rahayu&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nabilah Nurtika Salamah</style></author><author><style face="normal" font="default" size="100%">Widya Dwi Aryati</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as Adenosine A2A Antagonist using AutoDock and AutoDock Vina</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adenosine A2A antagonist</style></keyword><keyword><style  face="normal" font="default" size="100%">AutoDock</style></keyword><keyword><style  face="normal" font="default" size="100%">Autodock vina</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesian herbal database</style></keyword><keyword><style  face="normal" font="default" size="100%">Parkinson’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1219-1224</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Previous research found that Adenosine A&lt;sub&gt;2&lt;/sub&gt;A antagonist allows to reduce motor fluctuations, dyskinesia, protect from neurodegenerative disorder in Parkinson’s disease in the human brain which is chronic progressive of losing dopaminergic neurons. The aim of this study is to explore Indonesian herbal compounds as Adenosine A&lt;sub&gt;2&lt;/sub&gt;A inhibitor using virtual screening method. &lt;strong&gt;Methods: &lt;/strong&gt;In this study, virtual screening of Indonesian herbal database as Adenosine A&lt;sub&gt;2&lt;/sub&gt;A inhibitor was done by AutoDock and AutoDock Vina and was validated by database from A Directory of Useful Decoys: Enhanced (DUD-E). The method was validated by Enrichment Factor (EF) and Area Under Curve (AUC) of Receiver Operating Characteristics (ROC) curve &lt;strong&gt;Results: &lt;/strong&gt;Based on the validation results, grid box that was used in virtual screening using AutoDock is 60 × 60 × 60 with EF1% 16.5869 and AUC 0.8406. The two compounds &lt;em&gt;Chitranone &lt;/em&gt;and &lt;em&gt;3-O-Methylcalopocarpin&lt;/em&gt; with binding energy -10.19 and -9.55 kcal/mol, respectively showing interaction with Adenosine A&lt;sub&gt;2&lt;/sub&gt;A active site at residues ALA63, ILE66, ALA81, LEU85, PHE168, GLU169, MET177, TRP246, LEU249, ASN253 and ILE274. &lt;strong&gt;Conclusions:&amp;nbsp;&lt;/strong&gt;This study concludes that &lt;em&gt;Chitranone &lt;/em&gt;and &lt;em&gt;3-O-Methylcalopocarpin&lt;/em&gt; could be proposed to be developed as Adenosine A&lt;sub&gt;2&lt;/sub&gt;A antagonists.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1219</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nabilah Nurtika Salamah, Widya Dwi Aryati, Arry Yanuar* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Biomedical Computation and Drug Design Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Chindy Dwi Martinah</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as alpha-Amino-3- Hydroxy-5-Methyl-4 Isoxazolepropionic Acid (AMPA) Antagonist</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AMPA receptor</style></keyword><keyword><style  face="normal" font="default" size="100%">AutoDock</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal plants</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1204-1210</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Ischemic stroke is one type of circulatory disturbance caused by blood clots that block blood flow to the brain. One of the impact of ischemia is nerve cell damage due to excitotoxicity. Inhibition of the ionotropic glutamate receptor such as the AMPA receptor, becomes an essential approach to the treatment of ischemia. This study aims to explore the possibility of an Indonesian herbal compound as an AMPA receptor antagonist. &lt;strong&gt;Methods:&lt;/strong&gt; In this study, virtual screening of 2233 herbal compounds was performed by docking method using AutoDock to find the antagonist candidate of AMPA receptor from Indonesian herbal database. The virtual screening method was validated by an area under curve (AUC) of the ROC curve and enrichment factor (EF). Lipinski’s Rule of Five was used to filter the screening result. &lt;strong&gt;Results:&lt;/strong&gt; The validation of virtual screening result showed that AUC was 0.9385 and EF 1% was 23.5550. The screening result of Indonesian herbal database showed top five compound sanggenol O, blazeispirol X, progesterone, nimolicinol and boeravinone F (-8.51; -8.39; -8.19; -8.17; -8.08 kcal/mol, respectively) and have interaction with TYR61 and THR91 residues of AMPA receptor. &lt;strong&gt;Conclusion:&lt;/strong&gt; Five compounds of the Indonesia herbal database were shown as hits of AMPA receptor antagonist based on the docking method.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1204</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Chindy Dwi Martinah, Arry Yanuar* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Biomedical Computation and Drug Design Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi,</style></author><author><style face="normal" font="default" size="100%">Ayu Annissa</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database for Discovery of Procaspase-3 Activators Using Autodock and Autodock Vina</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptotic</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Procaspase-3 activator</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><pages><style face="normal" font="default" size="100%">xx-xx</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Cancer is a disease where body cell grows abnormal, spread to every part of human body. Previous studies have found excessive expression of Procaspase-3 on cancer that must be activated to Caspase-3 to induce apoptotic in cells. &lt;strong&gt;Methods:&lt;/strong&gt; Virtual screening of Indonesian Herbal Database was carried out to discover Procaspase-3 activators. This study was validated using enrichment factor (EF), receiver operating characteristics (ROC) area under curve (AUC) parameters. Among 1412 compounds were screened using Autodock and Autodock Vina software. &lt;strong&gt;Results&lt;/strong&gt;: The virtual screening results using Autodock obtained the best ten compounds with binding energy -8.28 ~ -9.31 kcal/mol and Autodock Vina obtained the best ten compounds with binding energy -8.1 ~ -8.8 kcal/mol. Both virtual screening software showed two compounds in common, i.e., betulinic acid and maslinic acid. &lt;strong&gt;Conclusion:&lt;/strong&gt; Betulinic acid interacts with Leu136A, Lys137A, Tyr195A and Pro201 residues in Autodock and Autodock Vina. While maslinic acid interacts with Leu136A, Lys137A and Pro201 residues in Autodock and Autodock Vina&lt;/p&gt;
</style></abstract><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">xx</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Ayu Annissa, Arry Yanuar* &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Ayu Annissa</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database for Discovery of Procaspase-3 Activators Using Autodock and Autodock Vina</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptotic</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Procaspase-3 activator</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><volume><style face="normal" font="default" size="100%">xx</style></volume><pages><style face="normal" font="default" size="100%">xx-xx</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Cancer is a disease where body cell grows abnormal, spread to every part of human body. Previous studies have found excessive expression of Procaspase-3 on cancer that must be activated to Caspase-3 to induce apoptotic in cells. &lt;strong&gt;Methods:&lt;/strong&gt; Virtual screening of Indonesian Herbal Database was carried out to discover Procaspase-3 activators. This study was validated using enrichment factor (EF), receiver operating characteristics (ROC) area under curve (AUC) parameters. Among 1412 compounds were screened using Autodock and Autodock Vina software. &lt;strong&gt;Results:&lt;/strong&gt; The virtual screening results using Autodock obtained the best ten compounds with binding energy -8.28 ~ -9.31 kcal/mol and Autodock Vina obtained the best ten compounds with binding energy -8.1 ~ -8.8 kcal/mol. Both virtual screening software showed two compounds in common, i.e., betulinic acid and maslinic acid.&lt;strong&gt; Conclusion:&lt;/strong&gt; Betulinic acid interacts with Leu136A, Lys137A, Tyr195A and Pro201 residues in Autodock and Autodock Vina. While maslinic acid interacts with Leu136A, Lys137A and Pro201 residues in Autodock and Autodock Vina.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">xx</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">xx</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Ayu Annissa, Arry Yanuar&lt;sup&gt;* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander Victory</style></author><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as Murine Double Minute-2 (MDM2) Inhibitor</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesian Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">MDM2</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">1184-1189</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Murine Double Minute-2 (MDM2) overexpression causes the p53 deficiency, so the role p53 as a cell regulator does not work in the case of cancer. &lt;strong&gt;Methods:&lt;/strong&gt; In this study, virtual screening of Indonesian herbal database to discover MDM2 inhibitors was carried out. Autodock and Autodock Vina validated with Directory of Useful Decoy-Enhanced (DUD-E). Validation parameters were performed with Enrichment Factor, Receiver Operating Characteristics, and Area Under Curve. &lt;strong&gt;Results:&lt;/strong&gt; The validation with the grid box 70x70x70 on Autodock resulting AUC value 0.72, while in Autodock Vina 0.43. Autodock Vina did not fulfilll the standard value but still used for comparison. Based on the virtual screening result, top ten compounds from Autodock are Nimolicinol, Jacoumaric acid, Isoarborinol, Lantic acid, Diosgenin, Theasaponin E1, Taraxasterol, Leucadenone C, Simiarenol, and Alpha-Amyrin were found to have strong interaction with MDM2, with binding energy (&amp;Delta;G) ranging from -8.83 to -9.65 kcal/mol. The Autodock Vina screening resulted in the identification of Yuehchukene, Morusin, Cyanidin, Leucadenone C, Roxburghine-B, Ocidentoside, Beta-sitosterol, Curine, Withangulatin, and Jacoumaric acid as potential inhibitors with binding energy (&amp;Delta;G) ranging from -8.7 to -9.4 kcal/mol. &lt;strong&gt;Conclusion:&lt;/strong&gt; Jacoumaric acid and Leucadenone C were shown to interact with the active site in MDM2 at residues Leu54, Ile61, Met62, and Ile99.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1184</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Alexander Victory, Rezi Riadhi Syahdi, Arry Yanuar*&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Candra Irawan</style></author><author><style face="normal" font="default" size="100%">Foliatini</style></author><author><style face="normal" font="default" size="100%">Hanafi</style></author><author><style face="normal" font="default" size="100%">Lilis Sulistiawaty</style></author><author><style face="normal" font="default" size="100%">Maman Sukiman</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Volatile Compound Analysis using GC-MS, Phytochemical Screening and Antioxidant Activities of the Husk of “Julang-Jaling” (Archidendron bubalinum (Jack) I.C Nielsen) from Lampung, Indonesia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antimicrobial activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Archidendron bubalinum (Jack) I.C Nielsen</style></keyword><keyword><style  face="normal" font="default" size="100%">GC-MS</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemicals</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/403</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">92-98</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &amp;ldquo;Julang-jaling&amp;rdquo; (&lt;em&gt;Archidendron bubalinum&lt;/em&gt; (Jack) I.C Nielsen) fruits are commonly used as traditional food and in the treatment of blood sugar and heart disease. However, the research about the phytochemicals of the parts of this plants and their bioactivity was rare. &lt;strong&gt;Objective:&lt;/strong&gt; The recent study was aimed to analyze volatile compounds in the extract of &amp;ldquo;julang-jaling&amp;rdquo; husks and evaluate their antioxidant and antimicrobial activities. &lt;strong&gt;Material and methods:&lt;/strong&gt; The extraction was conducted using &lt;em&gt;n-&lt;/em&gt;hexane, ethyl acetate, and methanol as extracting agent. The phytochemical assay was performed for all extracts, and followed by volatile compound analysis using GC-MS. The antioxidant assay was performed using DPPH method, and the antimicrobial activity was conducted using agar disc diffusion method. &lt;strong&gt;Results:&lt;/strong&gt; The phytochemical assay showed that all extracts of &amp;ldquo;julang-jaling&amp;rdquo; husks contain various phytoconstituents having potential bioactivity. All extracts exhibit antioxidant activity with different level of activity depend on the type of extract. The IC&lt;sub&gt;50&lt;/sub&gt; value were 273.57 ppm, 324.913 ppm, 735 ppm, for ethyl acetate, methanol and &lt;em&gt;n-&lt;/em&gt;hexane, respectively. All extracts were able to inhibit the growth of &lt;em&gt;Bacillus cereus&lt;/em&gt;, with the highest antimicrobial activity was gained for ethyl acetate extract. Both ethyl acetate and methanolic extract have antimicrobial activity toward &lt;em&gt;E. coli&lt;/em&gt;, but no extracts yield positive results for &lt;em&gt;Aspergillus flavus&lt;/em&gt; and &lt;em&gt;Aspergillus niger&lt;/em&gt;. &lt;strong&gt;Conclusion:&lt;/strong&gt; GC-MS analysis revealed the presence of hexadecanoic acids and their ester form in all extract, which might largely contribute in the antioxidant and antimicrobial activity.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">92</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Candra Irawan&lt;sup&gt;1&lt;/sup&gt;, Foliatini&lt;sup&gt;1&lt;/sup&gt;*, Hanafi&lt;sup&gt;2&lt;/sup&gt;, Lilis Sulistiawaty&lt;sup&gt;1&lt;/sup&gt; and Maman Sukiman&lt;sup&gt;3 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Analytical Chemistry Polytechnic of AKA Bogor, Bogor 16158, INDONESIA&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Food Industrial Quality Assurance Polytechnic of AKA Bogor, Bogor 16158, INDONESIA&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Industrial Waste Treatment Polytechnic of AKA Bogor, Bogor 16158, INDONESIA&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paula Carrión-Prieto</style></author><author><style face="normal" font="default" size="100%">Pablo Martín-Ramos</style></author><author><style face="normal" font="default" size="100%">Salvador Hernández-Navarro</style></author><author><style face="normal" font="default" size="100%">Iosody Silva-Castro</style></author><author><style face="normal" font="default" size="100%">Manuela Ramos-Silva</style></author><author><style face="normal" font="default" size="100%">Jesús Martín-Gil</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vibrational Analysis and Thermal Behavior of Salvia hispanica, Nigella sativa and Papaver somniferum Seeds</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">ATR-FTIR</style></keyword><keyword><style  face="normal" font="default" size="100%">Black cumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Chia</style></keyword><keyword><style  face="normal" font="default" size="100%">Poppy</style></keyword><keyword><style  face="normal" font="default" size="100%">Thermal analysis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://phcogj.com/fulltext/293</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">157-162</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Salvia hispanica&lt;/em&gt; L., &lt;em&gt;Nigella sativa&lt;/em&gt; L. and &lt;em&gt;Papaver somniferum&lt;/em&gt; L. are involved in opiate-dependent behavior. It is known that the seeds of these three herbs contain high amounts of antioxidants, which are helpful in disease prevention, but further research is needed on some of their other phytochemical components (terpene alkaloids, benzoquinones and others), which are claimed to affect human opioid receptors. &lt;strong&gt;Methods:&lt;/strong&gt; Seeds from the three afore mentioned plants have been studied by ATR-FTIR vibrational spectroscopy and thermo analytical techniques (TG/DTG, DTA and DSC). &lt;strong&gt;Results:&lt;/strong&gt; The infrared spectrum has confirmed the presence of the ester carbonyl of terpenoid alkaloids (such as nigellamine) and the fully conjugated cyclic dione structure of quinones (e.g., thymoquinone). As regards the thermal stability of these seeds, small differences have been observed in their thermal profiles (endothermic effects at around 333&amp;ordm;C for chia, 268&amp;ordm;C for black cumin and 319&amp;ordm;C for poppy seeds), which can be ascribed to their different content in carbohydrates. &lt;strong&gt;Conclusions:&lt;/strong&gt; The functional groups of the main active constituents and the thermal behavior of these three seeds have been elucidated.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">157</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Paula Carri&amp;oacute;n-Prieto,&lt;sup&gt;1&lt;/sup&gt; Pablo Mart&amp;iacute;n-Ramos,&lt;sup&gt;2&lt;/sup&gt;* Salvador Hern&amp;aacute;ndez-Navarro,&lt;sup&gt;1&lt;/sup&gt; Iosody Silva-Castro,&lt;sup&gt;1&lt;/sup&gt; Manuela Ramos- Silva,&lt;sup&gt;3&lt;/sup&gt; Jes&amp;uacute;s Mart&amp;iacute;n-Gil&lt;sup&gt;1 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Agriculture and Forestry Engineering Department, ETSIIAA, Universidad de Valladolid, Avenida de Madrid 44, 34004 Palencia, SPAIN.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Agricultural and Environmental Sciences, Higher Polytechnic School of Huesca, University of Zaragoza, Carretera de Cuarte, s/n, 22071 Huesca, SPAIN.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;CFisUC, Department of Physics, University of Coimbra, Rua Larga, P-3004-516 Coimbra, Portugal.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sunita Shailajan</style></author><author><style face="normal" font="default" size="100%">Sasikumar Menon</style></author><author><style face="normal" font="default" size="100%">Dipti Singh</style></author><author><style face="normal" font="default" size="100%">Gauri Swar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Validated analytical RP-HPLC method for quantitation of wedelolactone from Eclipta alba and marketed Ayurvedic formulations</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Eclipta alba</style></keyword><keyword><style  face="normal" font="default" size="100%">Formulations</style></keyword><keyword><style  face="normal" font="default" size="100%">RP-HPLC</style></keyword><keyword><style  face="normal" font="default" size="100%">Validation</style></keyword><keyword><style  face="normal" font="default" size="100%">Wedelolactone.</style></keyword><keyword><style  face="normal" font="default" size="100%">Whole plant</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">132-139</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align:justify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: &lt;em&gt;Eclipta alba&lt;/em&gt; Linn. (Asteraceae) is an important ingredient of several Ayurvedic formulations. The monograph on different parts of plant like flowers, leaves, roots are listed in Ayurvedic pharmacopeia of India. The plant is reported to be effective for broad range maladies like inflammation, reproductive problems of females etc. It is also used as a hepatoprotectant, analgesic, antibacterial and antidiabetic agent. Wedelolactone is used as a bioactive marker to establish the quality of the crude drug and its formulations. In the present study, wedelolactone-based standardization of &lt;em&gt;Eclipta alba&lt;/em&gt; and its quantitation from marketed herbal and Ayurvedic formulations has been documented using RP-HPLC. &lt;strong&gt;Methods&lt;/strong&gt;: In the current work, an isocratic method has been developed and validated to quantitate wedelolactone from whole plant of &lt;em&gt;Eclipta alba&lt;/em&gt;. This method is validated as per ICH guidelines and is used to quantitate the content of wedelolactone in polyherbal formulations like Liv52, Geriforte, Mahabhringaraj oil etc. &lt;strong&gt;Results: &lt;/strong&gt;The LOD is found to be 0.5 &amp;mu;g/mL and the LOQ is 1 &amp;mu;g/mL. The linearity range of response is from 5 &amp;mu;g/mL to 100 &amp;mu;g/mL. &lt;strong&gt;Conclusion:&lt;/strong&gt; The validated method is found to be simple, sensitive, accurate, rugged and reproducible. This developed method can be recommended for quality assurance and marker-based standardization of polyherbal formulations containing whole plant of &lt;em&gt;Eclipta alba.&lt;/em&gt;&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">132</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sunita Shailajan&lt;sup&gt;1&lt;/sup&gt;, Sasikumar Menon&lt;sup&gt;2&lt;/sup&gt;, Dipti Singh&lt;sup&gt;1&lt;/sup&gt;, Gauri Swar&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Herbal Research Lab, Ramnarain Ruia College, Matunga, Mumbai - 400 019, India&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institute for Advanced Training and Research in Interdisciplinary Science, Plot No. 194, Scheme No. 6, Road No. 15, Sion Koliwada, Sion (East), Mumbai-400 022, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>